Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Oncoxin-Viusid in cervical cancer and endometrial adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Adenocarcinoma

Drugs mentioned

• Oncoxin-Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Cervical Carcinoma Stage II, Cervical Carcinoma Stage III | Phase 2 | Status: COMPLETED